World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
34771
World Ranking
960
National Ranking
441

Research.com Recognitions

  • 2013 - Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH)

Overview

Karen L. Kotloff is affiliated with the University of Maryland, Baltimore in the United States. Their research primarily focuses on the field of Medicine, with a significant body of work in Infectious Diseases, Nutrition and Dietetics, Epidemiology, Pediatrics, Perinatology and Child Health, and Health. They have contributed extensively to topics such as Viral gastroenteritis research and epidemiology, Child Nutrition and Water Access, SARS-CoV-2 and COVID-19 Research, Vaccine Coverage and Hesitancy, Global Maternal and Child Health, Escherichia coli research studies, and Respiratory viral infections research.

Their recent published work includes:

  • Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico, 2021, New England Journal of Medicine
  • Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study, 2020, The Lancet Global Health
  • Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis, 2023, BMJ Global Health
  • Initial findings from a novel population-based child mortality surveillance approach: a descriptive study, 2020, The Lancet Global Health
  • Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial, 2022, Annals of Internal Medicine

Frequent co-authors of Karen L. Kotloff include:

  • Samba O. Sow
  • Milagritos D. Tapia
  • Inácio Mandomando
  • Richard Omore
  • Shabir A. Madhi

The scientist often publishes in the following venues:

  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Open Forum Infectious Diseases
  • JAMA Network Open
  • SSRN Electronic Journal

Kotloff's work spans multiple subfields and topics within Medicine, with a focus on infectious diseases and child health. Their contributions include significant studies on respiratory viruses, vaccination effectiveness and safety, and global health issues related to maternal and child populations.

They were awarded the title of Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH) in 2013.

Best Publications

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

    Lindsey R. Baden;Hana M El Sahly;Brandon J Essink;Karen Kotloff

  • Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.

    Karen L. Kotloff;James P. Nataro;William C. Blackwelder;Dilruba Nasrin

  • Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

    Ting Shi;David A. McAllister;Katherine L. O'Brien;Eric A. F. Simoes

  • Global Burden of Shigella Infections: Implications for Vaccine Development and Implementation of Control Strategies

    K. L. Kotloff;J. P. Winickoff;B. Ivanoff;J. D. Clemens

  • Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015

    Christopher Troeger;Mohammad Forouzanfar;Puja C. Rao;Ibrahim Khalil

  • Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016

    Christopher Troeger;Brigette F Blacker;Ibrahim A Khalil;Puja C Rao

  • The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children

    Robert B. Belshe;Paul M. Mendelman;John Treanor;James King

  • A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium

    William Checkley;William Checkley;A. Clinton White;Devan Jaganath;Michael J. Arrowood

  • Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study

    Jie Liu;James A Platts-Mills;Jane Juma;Furqan Kabir

  • Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study

    Katherine L. O'Brien;Henry C. Baggett;W. Abdullah Brooks;Daniel R. Feikin

  • 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

    Andi L Shane;Rajal K Mody;John A Crump;Phillip I Tarr

  • Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016.

    Ibrahim A Khalil;Christopher Troeger;Brigette F Blacker;Puja C Rao

  • Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

    Unknown

  • A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology.

    Lorenz von Seidlein;Deok Ryun Kim;Mohammad Ali;Hyejon Lee

  • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Iksung Cho

  • Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis

    You Li;Rachel M Reeves;Xin Wang;Quique Bassat

  • Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Harshvardhan B. Mehta

  • Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study

    Ibrahim A Khalil;Christopher Troeger;Puja C Rao;Brigette F Blacker

  • Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road

    Myron M. Levine;Karen L. Kotloff;Eileen M. Barry;Marcela F. Pasetti

  • The Global Enteric Multicenter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries: Epidemiologic and Clinical Methods of the Case/Control Study

    Karen L. Kotloff;William C. Blackwelder;Dilruba Nasrin;James P. Nataro

  • Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.

    Pierre Michetti;Christianna Kreiss;Karen L. Kotloff;Nadine Porta

  • Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development

    Sofie Livio;Nancy A. Strockbine;Sandra Panchalingam;Sharon M. Tennant

  • Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition

    Mihai Pop;Alan W Walker;Joseph Paulson;Brianna Lindsay

  • Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.

    John J Treanor;Karen Kotloff;Robert F Betts;Robert Belshe

  • The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS).

    Samba O. Sow;Khitam Muhsen;Dilruba Nasrin;William C. Blackwelder

Frequent Co-Authors

Myron M. Levine
Myron M. Levine University of Maryland, Baltimore
James P. Nataro
James P. Nataro University of Virginia
Martin Antonio
Martin Antonio London School of Hygiene & Tropical Medicine
Shabir A. Madhi
Shabir A. Madhi University of the Witwatersrand
David R. Murdoch
David R. Murdoch University of Otago
Robert F. Breiman
Robert F. Breiman Emory University
Daniel R. Feikin
Daniel R. Feikin Centers for Disease Control and Prevention
Maria Deloria Knoll
Maria Deloria Knoll Johns Hopkins University
Quique Bassat
Quique Bassat University of Barcelona
Pedro L. Alonso
Pedro L. Alonso University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology opens doors to diverse career paths in healthcare and life sciences. For individuals seeking education with flexibility, understanding what is the best degree for a convicted felon can be crucial when considering options that offer valuable credentials and career opportunities despite past challenges.

One promising path is becoming a functional medicine nurse, where microbiology knowledge supports holistic patient care and disease prevention through natural and integrative approaches.

Alternatively, the healthcare industry also demands experts in backend operations. Pursuing certification as a professional coder can lead to rewarding roles; learn more about certified professional coder salary and the essential skills needed to thrive in medical coding careers.

For those interested in management and data, a health information management degree offers access to administrative roles overseeing patient data systems. To understand the benefits, reviewing typical health information management degree salary and career growth is recommended.

Overall, integrating microbiology with these fields enhances job prospects and leverages scientific expertise in diverse, impactful ways.

Best Scientists Citing Karen L. Kotloff

Trending Scientists